Index by Author

November 1992; 2 (2)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Allen, M

    • Effect of freezing of the PCR buffer on the amplification specificity: allelic exclusion and preferential amplification of contaminating molecules. Genome Res. November 1992 2: 182-183; doi:10.1101/gr.2.2.182

  2. Andersen, J K

    • In vitro translation of proteins with terminal deletions by SP6 RNA polymerase-mediated transcription of PCR products. Genome Res. November 1992 2: 172-174; doi:10.1101/gr.2.2.172

B

  1. Borson, N D

  2. Breakefield, X O

    • In vitro translation of proteins with terminal deletions by SP6 RNA polymerase-mediated transcription of PCR products. Genome Res. November 1992 2: 172-174; doi:10.1101/gr.2.2.172

C

  1. Casareale, D

  2. Conant, R

    • Detection of the most common mutations causing beta-thalassemia in Mediterraneans using a multiplex amplification refractory mutation system (MARMS). Genome Res. November 1992 2: 163-166; doi:10.1101/gr.2.2.163

D

  1. Dahlen, P

    • Detection of mutation delta F508 in the cystic fibrosis gene using allele-specific PCR primers and time-resolved fluorometry. Genome Res. November 1992 2: 157-162; doi:10.1101/gr.2.2.157

  2. de Noronha, C M

    • Amplimers with 3'-terminal phosphorothioate linkages resist degradation by vent polymerase and reduce Taq polymerase mispriming. Genome Res. November 1992 2: 131-136; doi:10.1101/gr.2.2.131

  3. Diaco, R

  4. Dotti, G

    • Detection of the most common mutations causing beta-thalassemia in Mediterraneans using a multiplex amplification refractory mutation system (MARMS). Genome Res. November 1992 2: 163-166; doi:10.1101/gr.2.2.163

  5. Drewes, L R

F

  1. Fortina, P

    • Detection of the most common mutations causing beta-thalassemia in Mediterraneans using a multiplex amplification refractory mutation system (MARMS). Genome Res. November 1992 2: 163-166; doi:10.1101/gr.2.2.163

G

  1. Gorevic, P D

  2. Gorgone, G A

  3. Gustavsson, I

    • Reliable typing of DNA amplified from formalin-fixed tissue biopsies. Genome Res. November 1992 2: 175-176; doi:10.1101/gr.2.2.175

  4. Gyllensten, U

    • Reliable typing of DNA amplified from formalin-fixed tissue biopsies. Genome Res. November 1992 2: 175-176; doi:10.1101/gr.2.2.175
    • Effect of freezing of the PCR buffer on the amplification specificity: allelic exclusion and preferential amplification of contaminating molecules. Genome Res. November 1992 2: 182-183; doi:10.1101/gr.2.2.182

H

  1. Hedrum, A

    • Immunomagnetic recovery of Chlamydia trachomatis from urine with subsequent colorimetric DNA detection. Genome Res. November 1992 2: 167-171; doi:10.1101/gr.2.2.167

  2. Heidecker, G

    • A novel method for site-directed mutagenesis using PCR and uracil DNA glycosylase. Genome Res. November 1992 2: 124-130; doi:10.1101/gr.2.2.124

  3. Hitchcock, W

    • Detection of the most common mutations causing beta-thalassemia in Mediterraneans using a multiplex amplification refractory mutation system (MARMS). Genome Res. November 1992 2: 163-166; doi:10.1101/gr.2.2.163

  4. Hu, C Y

    • Effect of freezing of the PCR buffer on the amplification specificity: allelic exclusion and preferential amplification of contaminating molecules. Genome Res. November 1992 2: 182-183; doi:10.1101/gr.2.2.182

  5. Hurskainen, P

    • Detection of mutation delta F508 in the cystic fibrosis gene using allele-specific PCR primers and time-resolved fluorometry. Genome Res. November 1992 2: 157-162; doi:10.1101/gr.2.2.157

  6. Hurte, I

    • Reliable typing of DNA amplified from formalin-fixed tissue biopsies. Genome Res. November 1992 2: 175-176; doi:10.1101/gr.2.2.175

  7. Høgdall, E

    • Detection of mutation delta F508 in the cystic fibrosis gene using allele-specific PCR primers and time-resolved fluorometry. Genome Res. November 1992 2: 157-162; doi:10.1101/gr.2.2.157

I

  1. Iitiä, A

    • Detection of mutation delta F508 in the cystic fibrosis gene using allele-specific PCR primers and time-resolved fluorometry. Genome Res. November 1992 2: 157-162; doi:10.1101/gr.2.2.157

K

  1. Kaplan, G

    • Cystic fibrosis genotyping by direct PCR analysis of Guthrie blood spots. Genome Res. November 1992 2: 154-156; doi:10.1101/gr.2.2.154

  2. Kidd, K K

    • Modeling of heteroduplex formation during PCR from mixtures of DNA templates. Genome Res. November 1992 2: 112-116; doi:10.1101/gr.2.2.112

  3. Kury, F

L

  1. Larsen, J

  2. Lundeberg, J

    • Immunomagnetic recovery of Chlamydia trachomatis from urine with subsequent colorimetric DNA detection. Genome Res. November 1992 2: 167-171; doi:10.1101/gr.2.2.167

M

  1. MacConnell, P

  2. Malmgren, C

    • Reliable typing of DNA amplified from formalin-fixed tissue biopsies. Genome Res. November 1992 2: 175-176; doi:10.1101/gr.2.2.175

  3. Margiotta, M

  4. McClure, M

    • Cystic fibrosis genotyping by direct PCR analysis of Guthrie blood spots. Genome Res. November 1992 2: 154-156; doi:10.1101/gr.2.2.154

  5. Monokian, G

    • Detection of the most common mutations causing beta-thalassemia in Mediterraneans using a multiplex amplification refractory mutation system (MARMS). Genome Res. November 1992 2: 163-166; doi:10.1101/gr.2.2.163

  6. Mullins, J I

    • Amplimers with 3'-terminal phosphorothioate linkages resist degradation by vent polymerase and reduce Taq polymerase mispriming. Genome Res. November 1992 2: 131-136; doi:10.1101/gr.2.2.131

N

  1. Nuovo, G J

P

  1. Påhlson, C

    • Immunomagnetic recovery of Chlamydia trachomatis from urine with subsequent colorimetric DNA detection. Genome Res. November 1992 2: 167-171; doi:10.1101/gr.2.2.167

  2. Parrella, T

    • Detection of the most common mutations causing beta-thalassemia in Mediterraneans using a multiplex amplification refractory mutation system (MARMS). Genome Res. November 1992 2: 163-166; doi:10.1101/gr.2.2.163

  3. Pfeifer, G P

  4. Phillips, J A

    • Cystic fibrosis genotyping by direct PCR analysis of Guthrie blood spots. Genome Res. November 1992 2: 154-156; doi:10.1101/gr.2.2.154

  5. Pottathil, R

R

  1. Rappaport, E

    • Detection of the most common mutations causing beta-thalassemia in Mediterraneans using a multiplex amplification refractory mutation system (MARMS). Genome Res. November 1992 2: 163-166; doi:10.1101/gr.2.2.163

  2. Rashtchian, A

    • A novel method for site-directed mutagenesis using PCR and uracil DNA glycosylase. Genome Res. November 1992 2: 124-130; doi:10.1101/gr.2.2.124

  3. Raskin, S

    • Cystic fibrosis genotyping by direct PCR analysis of Guthrie blood spots. Genome Res. November 1992 2: 154-156; doi:10.1101/gr.2.2.154

  4. Ruano, G

    • Modeling of heteroduplex formation during PCR from mixtures of DNA templates. Genome Res. November 1992 2: 112-116; doi:10.1101/gr.2.2.112

S

  1. Saldeen, T

    • Reliable typing of DNA amplified from formalin-fixed tissue biopsies. Genome Res. November 1992 2: 175-176; doi:10.1101/gr.2.2.175

  2. Salo, W L

  3. Schneeberger, C

  4. Schwartz, E

    • Detection of the most common mutations causing beta-thalassemia in Mediterraneans using a multiplex amplification refractory mutation system (MARMS). Genome Res. November 1992 2: 163-166; doi:10.1101/gr.2.2.163

  5. Siitari, H

    • Detection of mutation delta F508 in the cystic fibrosis gene using allele-specific PCR primers and time-resolved fluorometry. Genome Res. November 1992 2: 157-162; doi:10.1101/gr.2.2.157

  6. Sparkman, D R

  7. Speiser, P

  8. Surrey, S

    • Detection of the most common mutations causing beta-thalassemia in Mediterraneans using a multiplex amplification refractory mutation system (MARMS). Genome Res. November 1992 2: 163-166; doi:10.1101/gr.2.2.163

T

  1. Tan, S S

    • Development of a sensitive reverse transcriptase PCR assay, RT-RPCR, utilizing rapid cycle times. Genome Res. November 1992 2: 137-143; doi:10.1101/gr.2.2.137

  2. Thornton, C G

    • A novel method for site-directed mutagenesis using PCR and uracil DNA glycosylase. Genome Res. November 1992 2: 124-130; doi:10.1101/gr.2.2.124

  3. Titlow, C C

    • In vitro translation of proteins with terminal deletions by SP6 RNA polymerase-mediated transcription of PCR products. Genome Res. November 1992 2: 172-174; doi:10.1101/gr.2.2.172

  4. Trofatter, J A

    • In vitro translation of proteins with terminal deletions by SP6 RNA polymerase-mediated transcription of PCR products. Genome Res. November 1992 2: 172-174; doi:10.1101/gr.2.2.172

U

  1. Uhlén, M

    • Immunomagnetic recovery of Chlamydia trachomatis from urine with subsequent colorimetric DNA detection. Genome Res. November 1992 2: 167-171; doi:10.1101/gr.2.2.167

V

  1. Vnencak-Jones, C

    • Cystic fibrosis genotyping by direct PCR analysis of Guthrie blood spots. Genome Res. November 1992 2: 154-156; doi:10.1101/gr.2.2.154

  2. Vuust, J

    • Detection of mutation delta F508 in the cystic fibrosis gene using allele-specific PCR primers and time-resolved fluorometry. Genome Res. November 1992 2: 157-162; doi:10.1101/gr.2.2.157

W

  1. Weis, J H

    • Development of a sensitive reverse transcriptase PCR assay, RT-RPCR, utilizing rapid cycle times. Genome Res. November 1992 2: 137-143; doi:10.1101/gr.2.2.137

Z

  1. Zeillinger, R

Current Issue

  1. February 2026, 36 (2)
  1. Current Issue
  1. Alert me to new issues of Genome Research